Comparison of DSM-5 Level 1 Cross-Cutting Symptom Measure (CCSM-5
4.7 (790) · € 20.99 · In Magazzino
Download scientific diagram | Comparison of DSM-5 Level 1 Cross-Cutting Symptom Measure (CCSM-5) scores between case and control groups from publication: Negative effects of accompanying psychiatric disturbances on functionality among adolescents with chronic migraine | Background Chronic migraine is a condition with gradually increasing prevalence among adolescents which causes severe headaches resulting in functionality loss. Factors contributing to migraine becoming chronic and negatively affecting quality of life in adolescence are still | Migraine, Advance Directives and Adolescents | ResearchGate, the professional network for scientists.
Measurement model of the Chinese version of the CCSM. CCSM, DSM-5
Dsm5 Cross-cutting Symptom Measures
Clinician ratings of the usefulness of the DSM-5 approach compared with
The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies
DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure Adult Name: Age: Sex: - Fill and Sign Printable Template Online
Utilization of the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure-Adult to Screen Healthy Volunteers for Research Studies - ScienceDirect
For better or for worse? A pre–post exploration of the impact of the COVID‐19 lockdown on cannabis users - Cousijn - 2021 - Addiction - Wiley Online Library
Frontiers A machine-learning model to predict suicide risk in Japan based on national survey data
Comparison of DSM-5 Level 1 Cross-Cutting Symptom Measure (CCSM-5)
Examining the factor structure of the DSM‐5 Level 1 cross‐cutting symptom measure - Gibbons - 2023 - International Journal of Methods in Psychiatric Research - Wiley Online Library
DSM-5 self-rated level 1 cross-cutting symptom measure (CCSM1): Proposal for a three-factors model and implications for the assessment of at-risk situations - ScienceDirect
Dsm5 Cross-cutting Symptom Measures
Clinician ratings of the usefulness of the DSM-5 approach compared with
Study protocol for a randomized controlled trial with rituximab for psychotic disorder in adults (RCT-Rits), BMC Psychiatry